Use and treatment of di-amino acid repeat-containing proteins associated with als

Abstract

Disclosed herein are methods and compositions for identifying and/or treating subjects having or likely to have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). Antibodies specific for one or more di-amino acid repeat-containing proteins are also provided herein.

Dependencies are inferred from the claim text.